Global Leukemia Therapeutics Market Analysis & Trends - Industry Forecast to 2025

  • ID: 4332944
  • Report
  • Region: Global
  • Accuray Research LLP
1 of 4
The Global Leukemia Therapeutics Market is poised to grow at a CAGR of around 17.5% over the next decade to reach approximately $2.6 billion by 2025.

FEATURED COMPANIES

  • AriadPharmaceuticals,Inc.
  • Celgene Corporation
  • Clavis Pharma Asa
  • Erytech Pharma
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • MORE
The Global Leukemia Therapeutics Market is poised to grow at a CAGR of around 17.5% over the next decade to reach approximately $2.6 billion by 2025. Some of the prominent trends that the market is witnessing include growing prevalence of chronic diseases, increasing research & development in Leukemia Therapeutics, and recent technological developments in therapies.

Based on leukemia type the market is categorized into chronic leukemia, acute leukemia, chronic myeloid leukemia, acute myeloid leukemia, chronic myelogenous leukemia, acute myelogenous leukemia, chronic lymphatic leukemia, and acute lymphatic leukemia. Furthermore, acute lymphatic leukemia sub segmented into acute biphenotypic leukemia, burkitt leukemia, precursor B acute lymphatic leukemia, and precursor T acute lymphatic leukemia. By diagnosis the market is segmented by biopsy, CT scan, and MRI.

Depending on the treatment the market is classified into chemotherapy, bone marrow transplant, immunotherapy, stem cell therapy, radiation therapy, targeted therapy, and surgery. On basis of Drugs the market is segmented by gleevec, ga101, dacogen, bosutinib, graspa, revlimid, omapro, marqibo, vasaroxine, tosedosat, sapacitabine, vidaza, and other drugs. By route of administration the market is segmented by intramuscular route, intrathecal route, subcutaneous route, intravenous route, and oral route.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
Middle East
  • Saudi Arabia
  • UAE
  • Rest of Middle East
Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
Rest of the World
  • Africa
  • Caribbean
Report Highlights:
  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2025, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2025
  • Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AriadPharmaceuticals,Inc.
  • Celgene Corporation
  • Clavis Pharma Asa
  • Erytech Pharma
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Growing prevalence of chronic diseases
3.1.2 Increasing research & development in Leukemia Therapeutics
3.1.3 Recent technological developments in therapies
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Leukemia Therapeutics Market, By Leukemia Type
4.1 Chronic Leukemia
4.1.1 Chronic Leukemia Market Forecast to 2025 (US$ MN)
4.2 Acute Leukemia
4.2.1 Acute Leukemia Market Forecast to 2025 (US$ MN)
4.3 Chronic Myeloid Leukemia
4.3.1 Chronic Myeloid Leukemia Market Forecast to 2025 (US$ MN)
4.4 Acute Myeloid Leukemia
4.4.1 Acute Myeloid Leukemia Market Forecast to 2025 (US$ MN)
4.5 Chronic Myelogenous Leukemia
4.5.1 Chronic Myelogenous Leukemia Market Forecast to 2025 (US$ MN)
4.6 Acute Myelogenous Leukemia
4.6.1 Acute Myelogenous Leukemia Market Forecast to 2025 (US$ MN)
4.7 Chronic Lymphatic Leukemia
4.7.1 Chronic Lymphatic Leukemia Market Forecast to 2025 (US$ MN)
4.8 Acute Lymphatic Leukemia
4.8.1 Acute Lymphatic Leukemia Market Forecast to 2025 (US$ MN)
4.8.1.1 Acute Biphenotypic Leukemia
4.8.1.1.1 Acute Biphenotypic Leukemia Market Forecast to 2025 (US$ MN)
4.8.1.2 Burkitt Leukemia
4.8.1.2.1 Burkitt Leukemia Market Forecast to 2025 (US$ MN)
4.8.1.3 Precursor B Acute Lymphatic Leukemia
4.8.1.3.1 Precursor B Acute Lymphatic Leukemia Market Forecast to 2025 (US$ MN)
4.8.1.4 Precursor T Acute Lymphatic Leukemia
4.8.1.4.1 Precursor T Acute Lymphatic Leukemia Market Forecast to 2025 (US$ MN)

5 Leukemia Therapeutics Market, By Diagnosis
5.1 Biopsy
5.1.1 Biopsy Market Forecast to 2025 (US$ MN)
5.2 CT Scan
5.2.1 CT Scan Market Forecast to 2025 (US$ MN)
5.3 MRI
5.3.1 MRI Market Forecast to 2025 (US$ MN)

6 Leukemia Therapeutics Market, By Treatment
6.1 Chemotherapy
6.1.1 Chemotherapy Market Forecast to 2025 (US$ MN)
6.2 Bone Marrow Transplant
6.2.1 Bone Marrow Transplant Market Forecast to 2025 (US$ MN)
6.3 Immunotherapy
6.3.1 Immunotherapy Market Forecast to 2025 (US$ MN)
6.4 Stem Cell Therapy
6.4.1 Stem Cell Therapy Market Forecast to 2025 (US$ MN)
6.5 Radiation Therapy
6.5.1 Radiation Therapy Market Forecast to 2025 (US$ MN)
6.6 Targeted Therapy
6.6.1 Targeted Therapy Market Forecast to 2025 (US$ MN)
6.7 Surgery
6.7.1 Surgery Market Forecast to 2025 (US$ MN)

8 Leukemia Therapeutics Market, By Drugs
8.1 Gleevec
8.1.1 Gleevec Market Forecast to 2025 (US$ MN)
8.2 GA101
8.2.1 GA101 Market Forecast to 2025 (US$ MN)
8.3 Dacogen
8.3.1 Dacogen Market Forecast to 2025 (US$ MN)
8.4 Bosutinib
8.4.1 Bosutinib Market Forecast to 2025 (US$ MN)
8.5 Graspa
8.5.1 Graspa Market Forecast to 2025 (US$ MN)
8.6 Revlimid
8.6.1 Revlimid Market Forecast to 2025 (US$ MN)
8.7 Omapro
8.7.1 Omapro Market Forecast to 2025 (US$ MN)
8.8 Marqibo
8.8.1 Marqibo Market Forecast to 2025 (US$ MN)
8.9 Vasaroxine
8.9.1 Vasaroxine Market Forecast to 2025 (US$ MN)
8.10 Tosedosat
8.10.1 Tosedosat Market Forecast to 2025 (US$ MN)
8.11 Sapacitabine
8.11.1 Sapacitabine Market Forecast to 2025 (US$ MN)
8.12 Vidaza
8.12.1 Vidaza Market Forecast to 2025 (US$ MN)
8.13 Other Drugs
8.13.1 Other Drugs Market Forecast to 2025 (US$ MN)

9 Leukemia Therapeutics Market, By Route of Administration
9.1 Intramuscular Route
9.1.1 Intramuscular Route Market Forecast to 2025 (US$ MN)
9.2 Intrathecal Route
9.2.1 Intrathecal Route Market Forecast to 2025 (US$ MN)
9.3 Subcutaneous Route
9.3.1 Subcutaneous Route Market Forecast to 2025 (US$ MN)
9.4 Intravenous Route
9.4.1 Intravenous Route Market Forecast to 2025 (US$ MN)
9.5 Oral Route
9.5.1 Oral Route Market Forecast to 2025 (US$ MN)

10 Leukemia Therapeutics Market, By Geography
10.1 North America
10.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
10.1.1.1 US
10.1.1.2 Canada
10.1.1.3 Mexico
10.2 Europe
10.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
10.2.1.1 Germany
10.2.1.2 U.K.
10.2.1.3 Italy
10.2.1.4 France
10.2.1.5 Spain
10.2.1.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
10.3.1.1 Japan
10.3.1.2 China
10.3.1.3 India
10.3.1.4 Australia
10.3.1.5 New Zealand
10.3.1.6 Rest of APAC
10.4 Middle East
10.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
10.4.1.1 Saudi Arabia
10.4.1.2 UAE
10.4.1.3 Rest of Middle East
10.5 Latin America
10.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
10.5.1.1 Argentina
10.5.1.2 Brazil
10.5.1.3 Rest of Latin America
10.6 Rest of the World (RoW)
10.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
10.6.1.1 Africa
10.6.1.2 Caribbean

11 Key Player Activities
11.1 Mergers & Acquisitions
11.2 Partnerships, Joint Venture’s, Collaborations and Agreements
11.3 Product Launch & Expansions
11.4 Other Activities

12 Leading Companies
12.1 Ambit Biosciences Corporation
12.2 AriadPharmaceuticals, Inc.
12.3 Biogen Idec, Inc.
12.4 Bristol Myers Squibb Company (BMS)
12.5 Celgene Corporation
12.6 Cephalon Inc
12.7 Clavis Pharma Asa
12.8 Eisai Co. Ltd.
12.9 Erytech Pharma
12.10 Genzyme Corporation
12.11 GlaxoSmithKline plc
12.12 Novartis AG
12.13 Pfizer Inc.
12.14 Roche Holding AG
12.15 Sanofi

List of Tables
Table 1 Global Leukemia Therapeutics Market By Region, Market Forecast (2014-2025) (US $MN)
Table 2 Global Leukemia Therapeutics Market By Leukemia Type, Market Forecast (2014-2025) (US $MN)
Table 3 Global Leukemia Therapeutics Market By Chronic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 4 Global Leukemia Therapeutics Market By Acute Leukemia, Market Forecast (2014-2025) (US $MN)
Table 5 Global Leukemia Therapeutics Market By Chronic Myeloid Leukemia, Market Forecast (2014-2025) (US $MN)
Table 6 Global Leukemia Therapeutics Market By Acute Myeloid Leukemia, Market Forecast (2014-2025) (US $MN)
Table 7 Global Leukemia Therapeutics Market By Chronic Myelogenous Leukemia, Market Forecast (2014-2025) (US $MN)
Table 8 Global Leukemia Therapeutics Market By Acute Myelogenous Leukemia, Market Forecast (2014-2025) (US $MN)
Table 9 Global Leukemia Therapeutics Market By Chronic Lymphatic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 10 Global Leukemia Therapeutics Market By Acute Lymphatic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 11 Global Leukemia Therapeutics Market By Acute Biphenotypic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 12 Global Leukemia Therapeutics Market By Burkitt Leukemia, Market Forecast (2014-2025) (US $MN)
Table 13 Global Leukemia Therapeutics Market By Precursor B Acute Lymphatic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 14 Global Leukemia Therapeutics Market By Precursor T Acute Lymphatic Leukemia, Market Forecast (2014-2025) (US $MN)
Table 15 Global Leukemia Therapeutics Market By Diagnosis, Market Forecast (2014-2025) (US $MN)
Table 16 Global Leukemia Therapeutics Market By Biopsy, Market Forecast (2014-2025) (US $MN)
Table 17 Global Leukemia Therapeutics Market By CT Scan, Market Forecast (2014-2025) (US $MN)
Table 18 Global Leukemia Therapeutics Market By MRI, Market Forecast (2014-2025) (US $MN)
Table 19 Global Leukemia Therapeutics Market By Treatment, Market Forecast (2014-2025) (US $MN)
Table 20 Global Leukemia Therapeutics Market By Chemotherapy, Market Forecast (2014-2025) (US $MN)
Table 21 Global Leukemia Therapeutics Market By Bone Marrow Transplant, Market Forecast (2014-2025) (US $MN)
Table 22 Global Leukemia Therapeutics Market By Immunotherapy, Market Forecast (2014-2025) (US $MN)
Table 23 Global Leukemia Therapeutics Market By Stem Cell Therapy, Market Forecast (2014-2025) (US $MN)
Table 24 Global Leukemia Therapeutics Market By Radiation Therapy, Market Forecast (2014-2025) (US $MN)
Table 25 Global Leukemia Therapeutics Market By Targeted Therapy, Market Forecast (2014-2025) (US $MN)
Table 26 Global Leukemia Therapeutics Market By Surgery, Market Forecast (2014-2025) (US $MN)
Table 27 Global Leukemia Therapeutics Market By Drugs, Market Forecast (2014-2025) (US $MN)
Table 28 Global Leukemia Therapeutics Market By Gleevec, Market Forecast (2014-2025) (US $MN)
Table 29 Global Leukemia Therapeutics Market By GA101, Market Forecast (2014-2025) (US $MN)
Table 30 Global Leukemia Therapeutics Market By Dacogen, Market Forecast (2014-2025) (US $MN)
Table 31 Global Leukemia Therapeutics Market By Bosutinib, Market Forecast (2014-2025) (US $MN)
Table 32 Global Leukemia Therapeutics Market By Graspa, Market Forecast (2014-2025) (US $MN)
Table 33 Global Leukemia Therapeutics Market By Revlimid, Market Forecast (2014-2025) (US $MN)
Table 34 Global Leukemia Therapeutics Market By Omapro, Market Forecast (2014-2025) (US $MN)
Table 35 Global Leukemia Therapeutics Market By Marqibo, Market Forecast (2014-2025) (US $MN)
Table 36 Global Leukemia Therapeutics Market By Vasaroxine, Market Forecast (2014-2025) (US $MN)
Table 37 Global Leukemia Therapeutics Market By Tosedosat, Market Forecast (2014-2025) (US $MN)
Table 38 Global Leukemia Therapeutics Market By Sapacitabine, Market Forecast (2014-2025) (US $MN)
Table 39 Global Leukemia Therapeutics Market By Vidaza, Market Forecast (2014-2025) (US $MN)
Table 40 Global Leukemia Therapeutics Market By Other Drugs, Market Forecast (2014-2025) (US $MN)
Table 41 Global Leukemia Therapeutics Market By Route of Administration, Market Forecast (2014-2025) (US $MN)
Table 42 Global Leukemia Therapeutics Market By Intramuscular Route, Market Forecast (2014-2025) (US $MN)
Table 43 Global Leukemia Therapeutics Market By Intrathecal Route, Market Forecast (2014-2025) (US $MN)
Table 44 Global Leukemia Therapeutics Market By Subcutaneous Route, Market Forecast (2014-2025) (US $MN)
Table 45 Global Leukemia Therapeutics Market By Intravenous Route, Market Forecast (2014-2025) (US $MN)
Table 46 Global Leukemia Therapeutics Market By Oral Route, Market Forecast (2014-2025) (US $MN)

Note: Regional tables are presented in the similar manner as the above
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ambit Biosciences Corporation
  • AriadPharmaceuticals,Inc.
  • Biogen Idec, Inc.
  • Bristol Myers Squibb Company (BMS)
  • Celgene Corporation
  • Cephalon Inc
  • Clavis Pharma Asa
  • Eisai Co. Ltd.
  • Erytech Pharma
  • Genzyme Corporation
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll